

At Stanford University, the conduct of research involving human stem cells is governed by policy, incorporating both U.S., State of California and California Institute for Regenerative Medicine (CIRM) regulations, and reviewed by the University's Stem Cell Research Oversight (SCRO) Panel.
All research that involves the use of human stem cells, human embryos, or their derivatives must be reviewed and approved by the SCRO Panel prior to activity commencement. In order to obtain approval for your activities, you'll need to complete and submit an electronic protocol application form, detailing your intended use of stem cells. In general, protocol applications that require full SCRO review and are received by the first working day of the month will be reviewed at the SCRO Panel meeting on the second Friday of the following month.
The SCRO Panel meets the second Friday of every month.